We found that, in gastric cancer patients, immune-related biomarkers, such as T-cell density, dMMR status, PD-L1 expression, and the T-cell activation-related gene signature, were significantly lower in metastatic tumors than in primary tumors. The gene discussed is CD274; the disease is metastatic neoplasm.